Patent · US Active

Modified exedins and uses thereof

US8097586B2 · kind B2 · utility

18Cited by

2References

13Claims

0Family size

Assignee

Wuxi Grandchamp Pharmaceutical Technology Co., Ltd. · CN

Inventors

Aifeng Lv · Lianyungang, CN
Changan Sun · Shanghai, CN
Yali Wang · Lianyungang, CN

Key dates

Filing date	Jan 10, 2006
Grant date	Jan 17, 2012
Priority date	—
Expiry date	Jul 25, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel exendins with modifications at one or more of following positions: 2, 14, 27 or 28 and polyethylene glycol derivatives thereof are provided. These compounds are useful in treating type 2 diabetes as GLP-1 receptor agonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.